• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insiders Buying Westlake Chemical Partners And 2 Other Stocks

    4/2/24 9:06:23 AM ET
    $ONCT
    $WLKP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Chemicals
    Industrials
    Get the next $ONCT alert in real time by email

    Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    Sow Good

    • The Trade: Sow Good Inc. (OTC:SOWG) Director Lyle Berman acquired a total of 68,966 shares an average price of $7.25. To acquire these shares, it cost around $500,004.
    • What’s Happening: On March 28, Sow Good announced a $3.7 million private placement.
    • What Sow Good Does: Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups.

    Oncternal Therapeutics

    • The Trade: Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Director Robert James Wills acquired a total of 6,914 shares at an average price of $8.48. To acquire these shares, it cost around $58,602.
    • What’s Happening: On March 7, Oncternal Therapeutics posted upbeat quarterly sales.
    • What Oncternal Therapeutics Does: Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need.

    Don’t forget to check out our premarket coverage here

    Westlake Chemical Partners

    • The Trade: Westlake Chemical Partners LP (NYSE:WLKP) SVP, Olefin Material & Corp Pr Andrew Kenner bought a total of 5,000 shares at an average price of $22.23. To acquire these shares, it cost around $111,150.
    • What’s Happening: On Feb. 20, Westlake Chemical posted downbeat quarterly results.
    • What Westlake Chemical Partners Does: Westlake Chemical Partners LP is a part of the chemical industry in the United States.

     

    Check This Out: Dave & Buster's Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

    Get the next $ONCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ONCT
    $WLKP

    CompanyDatePrice TargetRatingAnalyst
    Westlake Chemical Partners LP
    $WLKP
    3/2/2022$30.00 → $31.00Buy
    Deutsche Bank
    Oncternal Therapeutics Inc.
    $ONCT
    2/24/2022$5.00Buy
    BTIG
    Oncternal Therapeutics Inc.
    $ONCT
    2/24/2022$50.00Buy
    BTIG
    Westlake Chemical Partners LP
    $WLKP
    7/16/2021$27.00Buy → Underperform
    BofA Securities
    More analyst ratings

    $ONCT
    $WLKP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deutsche Bank reiterated coverage on Westlake Chemical with a new price target

    Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously

    3/2/22 9:14:17 AM ET
    $WLKP
    Major Chemicals
    Industrials

    BTIG initiated coverage on Oncternal Therapeutics with a new price target

    BTIG initiated coverage of Oncternal Therapeutics with a rating of Buy and set a new price target of $5.00

    2/24/22 7:15:03 AM ET
    $ONCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BTIG initiated coverage on Oncternal Therapeutics with a new price target

    BTIG initiated coverage of Oncternal Therapeutics with a rating of Buy and set a new price target of $50.00

    2/24/22 7:15:03 AM ET
    $ONCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ONCT
    $WLKP
    SEC Filings

    View All

    SEC Form S-3 filed by Westlake Chemical Partners LP

    S-3 - Westlake Chemical Partners LP (0001604665) (Filer)

    3/4/26 5:08:27 PM ET
    $WLKP
    Major Chemicals
    Industrials

    SEC Form 10-K filed by Westlake Chemical Partners LP

    10-K - Westlake Chemical Partners LP (0001604665) (Filer)

    3/4/26 1:01:38 PM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners LP filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Westlake Chemical Partners LP (0001604665) (Filer)

    2/24/26 7:22:35 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $ONCT
    $WLKP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Westlake Chemical Partners LP Filed Annual Report

    Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on March 4, 2026. A copy of this 10-K may be found on the Partnership's website, www.wlkpartners.com, by selecting the "Investor Relations" tab, then "SEC Filings." Unitholders of the Partnership may receive a hard copy of its Annual Report on Form 10-K, including complete audited financial statements, free of charge. Requests should be submitted in writing to Westlake Chemical Partners LP – 2025 Form 10-K, 2801 Post Oak Blvd., Suite 600, Houston, TX 77056. About Westlake Chemical Part

    3/4/26 4:15:00 PM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2025 Results

    Strong fourth quarter coverage ratio of 1.13x following the completion of the Petro 1 turnaround Declared quarterly distribution of $0.4714 per unit; 46th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2025 of $14.5 million, or $0.41 per limited partner unit, which was relatively in line with fourth quarter 2024 net income of $15.0 million. Cash flows from operating activities in the fourth quarter of 2025 were $120.4 million, a decrease of $12.1 million compared to fourth quarter 2024 cash flows from operating activities of $132.5 million, due to lower

    2/24/26 6:30:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners Announce Fourth Quarter and Full Year Earnings for 2025 Conference Call

    Westlake Chemical Partners (NYSE:WLKP) will release its fourth quarter and full year 2025 earnings prior to the market opening on Tuesday, February 24, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI75a6b835bd404a6196626a29eaf3bd8f. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/

    2/10/26 9:00:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $ONCT
    $WLKP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Gilson Jean-Marc bought $2,025 worth of Common Units (95 units at $21.25), increasing direct ownership by 0.81% to 11,803 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/29/25 3:36:25 PM ET
    $WLKP
    Major Chemicals
    Industrials

    President and CEO Gilson Jean-Marc bought $163,637 worth of Common Units (7,461 units at $21.93), increasing direct ownership by 176% to 11,708 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:56 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Amendment: President and CEO Gilson Jean-Marc bought $7,344 worth of Common Units (320 units at $22.95), increasing direct ownership by 10% to 3,427 units (SEC Form 4)

    4/A - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:42 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $ONCT
    $WLKP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Gilson Jean-Marc bought $2,025 worth of Common Units (95 units at $21.25), increasing direct ownership by 0.81% to 11,803 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/29/25 3:36:25 PM ET
    $WLKP
    Major Chemicals
    Industrials

    President and CEO Gilson Jean-Marc bought $163,637 worth of Common Units (7,461 units at $21.93), increasing direct ownership by 176% to 11,708 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:56 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Amendment: President and CEO Gilson Jean-Marc bought $7,344 worth of Common Units (320 units at $22.95), increasing direct ownership by 10% to 3,427 units (SEC Form 4)

    4/A - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:42 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $ONCT
    $WLKP
    Leadership Updates

    Live Leadership Updates

    View All

    Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

    Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Robert Wills, Ph.D., to its Board of Directors, effective immediately April 7, 2025. Dr. Wills brings decades of experience in the pharmaceutical and biotechnology industries, with a distinguished career in drug development, corporate strategy, and executive leadership. "On behalf of the entire Board of Directors, it is a pleasure to welcome Rob, a highly accomplished industry veteran, to our team," said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc.

    4/10/25 8:30:00 AM ET
    $ACOG
    $CBAY
    $MIST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

    SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (NASDAQ:ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the approval of an inducement award to one new employee, Anne C. Hansen, who is joining Oncternal as Senior Director, Clinical Data Management. The award will be made on May 1, 2024 under Oncternal's 2021 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Oncternal as an inducement to join the Company. The award will consist of an option to purchase 5,000 shares of Oncternal common stock. The option will have a 10-year term

    5/1/24 9:00:00 AM ET
    $ONCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer

    SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (NASDAQ:ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced it will participate in a virtual fireside chat on the Treatment Landscape & New Treatment Options for Prostate Cancer. Oncternal's President and CEO, James Breitmeyer, M.D., Ph.D. will join Oppenheimer Senior Research Biotech Analyst, Hartaj Singh and a prostate cancer Key Opinion Leader on Tuesday, March 19th, 2024 at 11:00 AM ET. Dr. Breitmeyer will discuss the development of Oncternal's novel dual-acting androgen receptor inhibitor, ONCT-534, the ongoing Phase 1/2 clinical trial ONC

    3/15/24 9:00:00 AM ET
    $ONCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ONCT
    $WLKP
    Financials

    Live finance-specific insights

    View All

    Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2025 Results

    Strong fourth quarter coverage ratio of 1.13x following the completion of the Petro 1 turnaround Declared quarterly distribution of $0.4714 per unit; 46th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2025 of $14.5 million, or $0.41 per limited partner unit, which was relatively in line with fourth quarter 2024 net income of $15.0 million. Cash flows from operating activities in the fourth quarter of 2025 were $120.4 million, a decrease of $12.1 million compared to fourth quarter 2024 cash flows from operating activities of $132.5 million, due to lower

    2/24/26 6:30:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners Announce Fourth Quarter and Full Year Earnings for 2025 Conference Call

    Westlake Chemical Partners (NYSE:WLKP) will release its fourth quarter and full year 2025 earnings prior to the market opening on Tuesday, February 24, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI75a6b835bd404a6196626a29eaf3bd8f. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/

    2/10/26 9:00:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners LP Announces Third Quarter 2025 Results

    Renewed Ethylene Sales Agreement through 2027 at existing terms Declared quarterly distribution of $0.4714 per unit; 45th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2025 of $14.7 million, or $0.42 per limited partner unit, which was below third quarter 2024 net income of $18.1 million. Cash flows from operating activities in the third quarter of 2025 were $105.2 million, a decrease of $20.9 million compared to third quarter 2024 cash flows from operating activities of $126.1 million. For the three months ended September 30, 2025, MLP distributable ca

    10/30/25 6:30:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $ONCT
    $WLKP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Westlake Chemical Partners LP (Amendment)

    SC 13D/A - Westlake Chemical Partners LP (0001604665) (Subject)

    2/14/24 4:19:23 PM ET
    $WLKP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Westlake Chemical Partners LP (Amendment)

    SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)

    2/14/24 2:02:09 PM ET
    $WLKP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Westlake Chemical Partners LP (Amendment)

    SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)

    2/12/24 4:43:59 PM ET
    $WLKP
    Major Chemicals
    Industrials